Laughter therapy could provide a novel, accessible, and low-cost approach for individuals managing chronic obstructive pulmonary disease (COPD), according to new research from Turkey. The study suggests that incorporating laughter exercises might help patients breathe easier and improve their overall well-being.
COPD affects more than 35 million Americans, with an estimated 16 million adults diagnosed in the U.S. alone. The condition, characterized by swelling and irritation that limits airflow in and out of the lungs, can make daily activities like walking, bathing, and dressing feel significantly challenging due to shortness of breath. This can lead to fatigue, reduced energy, and difficulty with routine tasks such as household chores and shopping. Beyond physical symptoms, COPD can also impact cognitive functions, affecting concentration, memory, and decision-making.
Treatments for COPD often involve prescribed medications like inhalers and bronchodilators, along with emergency interventions. The American Lung Association reports that the average annual medical cost for a person with COPD is approximately $16,000, compared to $6,000 for those without the disease. Given the financial and physical burden, researchers at Hacettepe University Faculty of Nursing in Turkey sought to explore simple, low-cost methods to supplement existing care.
"Laughter therapy had already shown promising results in a number of other chronic conditions," said Dr. Goncagul Aldan, a lecturer and nurse who presented the research at the European Respiratory Society Congress in Spain. "Its accessible, enjoyable nature suggests it could equally benefit COPD patients, not only in coping with the daily stress of living with a chronic illness, but also in directly supporting their respiratory health."
The trial involved 63 COPD patients at Ankara Bilkent City Hospital. Participants were divided into three groups: one engaged in pursed-lip breathing exercises, a recognized technique for COPD management; another group underwent laughter therapy; and a control group received no intervention. Pursed-lip breathing involves inhaling through the nose and exhaling through puckered lips to prolong exhalation, helping to keep airways open and release trapped air.
The laughter therapy regimen consisted of 30-minute sessions, three times a week for eight weeks. These sessions included exercises such as rhythmic clapping with vocal sounds, playful laughter exercises mimicking sounds like a motorcycle starting or a lion's roar, a laughter meditation encouraging spontaneous laughter, and relaxation with calm breathing and smiling.
Researchers observed that both pursed-lip breathing and laughter therapy groups reported improved breathing ease. These benefits persisted for a month after the eight-week program concluded. While patients in the intervention groups experienced better overall health, their need for medical care remained consistent with the control group.
"Laughter may exercise the breathing muscles, promote deeper exhalation, and trigger the release of endorphins, offering both physical and emotional relief," Aldan explained. "Laughter therapy aims to evoke the effects of genuine laughter in the body. However, the mechanisms behind laughter therapy in COPD remain poorly understood, and more comprehensive research is needed."
The researchers hope that laughter therapy can become an additional tool for COPD patients, offering a non-pharmacological option that can be performed at home without specialized equipment or professional support. This approach could potentially alleviate some of the daily struggles associated with the chronic condition.